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1 Abstract 
Background: Colistin is a polypeptide antibiotic extensively used as a last resort agent 
in the treatment of multi drug resistant (MDR) Gram-negative bacteria. Its bactericidal 
potency is associated with nephrotoxic adverse effects that limit the use in clinical 
practice. Little is known about the exact mechanism of colistin-induced cellular 
damage, and efficient protective strategies are lacking. 
Aim: To characterize the effect of colistin at the mitochondrial level and to explore the 
use of L-carnitine as a potential protective agent. 
Methods: The impact of colistin exposure on mitochondria was evaluated in intact wild 
type HEK293 cells (WT-HEK293 cells) and in freshly isolated mitochondria from both 
WT-HEK293 cells and mouse kidney. The impact of intracellular L-carnitine on colistin-
induced mitochondrial toxicity was evaluated in HEK293 cells stably transfected with 
the low affinity L-carnitine transporter SLC22A4 (OCTN1).  
Results: We found that OCTN1-HEK293 cells had significantly higher intracellular 
levels of L-carnitine as compared with WT-HEK293 cells. After 48-hour exposure to 
colistin at an extracellular concentration of 100 M, a marked mitochondrial membrane 
depolarization was induced in WT-HEK293 cells whereas mitochondria from OCTN1-
HEK293 cells were not affected. Mitochondria exposed to colistin were rapidly 
shrunken and depolarized. Mitochondrial membrane depolarization was fully abolished 
by ADP, the most potent inhibitor of the mitochondrial permeability transition pore 
(MPTP). L-carnitine, recently reported as an inhibitor of the MPTP, failed to directly 
protect from the depolarization. 
Conclusions: Colistin had a direct effect on mitochondrial function by inducing a rapid 
depolarization. The protective effect of ADP suggests that colistin-induced 
depolarization might be secondary to the opening of the MPTP. L-carnitine showed a 
protective effect towards mitochondria when cells were exposed to colistin, but not 
when isolated mitochondria were exposed to colistin, suggesting that L-carnitine 
protects mitochondria through an indirect mechanism.  
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2 Abbreviations 
ADP   Adenosine diphosphate 
AKI    Acute kidney injury 
AMP   Adenosine monophosphate 
ATP   Adenosine triphosphate 
AUC   Area under the curve 
BCA   Bicinchoninic acid 
BSA   Bovine serum albumin 
CPT   Carnitine palmitoyltransferase 
DNA   Deoxyribonucleic acid 
FADH   Flavin adenine dinucleotide 
FBS    Fetal bovine serum 
HEK-239   Human embryonic kidney cells 239 
IMM    Inner mitochondrial membrane 
MDR   Multi drug resistant 
MIC    Minimum inhibitory concentration 
MPTP   Mitochondrial permeability transition pore 
NAD   Nicotinamide adenine dinucleotide 
OCT   Organic cation transporter 
OCTN  Organic cation transporter, novel 
OMM   Outer mitochondrial membrane 
PBS   Phosphate-buffered saline 
R123   Rhodamine 123 
RNA   Ribonucleic acid 
SDHA   Succinate dehydrogenase complex flavoprotein subunit A 
TOMM  Translocase of the outer mitochondrial membrane 
WT    Wild type 
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3 Introduction 
3.1 Antibiotic classification and mechanisms of action 
Infectious diseases threaten humanity since ancient times. Whether we look at a 
deadly world-spanning pandemic caused by Yersinia pestis in the middle ages, at life-
threatening meningococcal meningitis in newborns, or at cumbersome ubiquitous 
urinary tract infections in old age homes, the discovery and development of effective 
antimicrobial drugs have greatly improved our chances for survival and revolutionized 
modern medicine. While several hundred antibiotics are currently in clinical use, all act 
according to a few basic pharmaceutical mechanisms of action. Katzung et al defined 
two major groups of antimicrobial substances; “an antimicrobial substance that can 
eradicate an infection in the absence of host defense mechanisms and kills bacteria is 
classified as bactericidal; an antimicrobial drug that inhibits antimicrobial growth but 
requires host defense mechanisms to eradicate the infection and does not kill bacteria 
is labelled bacteriostatic” (Bertram G. Katzung, 2015).The bactericidal group includes 
the following classes: β-Lactam antibiotics, which are named after their chemical 
structures that contain a beta-lactam ring  block the synthesis of bacterial murein, an 
essential component of bacterial membranes (Bertram G. Katzung, 2015). Subgroups 
contain the oldest of the commercially used antibiotics, the penicillins (e.g. penicillin G, 
aminopenicillin), its derivatives and, because of their excessive spectrum only very 
restrictively prescribed penems (e.g. carbapenem, meropenem) and the 
cephalosporins (e.g. ceftriaxon, cefepem) (Freissmuth, 2016). The sulfonamides (e.g. 
co-trimoxazole, trimethoprim) show efficacy against actinomycetes and chlamydia 
(acne, sexual transmitted diseases) by inhibiting the synthesis of tetrahydrofolic acid, 
which is important for the synthesis of DNA and RNA (Freissmuth, 2016). The 
polymyxins (e.g. polymyxin B, colistin), effective against Actinobacter, Pseudomonas 
aeroguinosa and Klebsiella (nosocomial infections) are known to disintegrate the outer 
bacterial membrane (Zavascki et al., 2007). Rifamycins (rifampicin), known for their 
efficacy against mycobacteria (tuberculosis, lepra), work by blocking parts of the RNA-
synthesis (Rothstein, 2016). There are also antibiotics that hinder the protein synthesis 
of organells, making them bacteriostatic by slowing the metabolism of bacteria. They 
include the tetracyclins (e.g. doxycycline), used against bacteria without outer 
membranes like Borrelia (e.g. erythema migrans) (Chukwudi, 2016). The macrolides 
(e.g. clarythromycin, erythromycin) specifically alter bacterial ribosome function and 
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hinder protein synthesis, due to their penicillin-like efficacy they are often used as a 
substitute antibiotic for patients that are allergic to penicillin in gram-negative bacterial 
infections (Kwiatkowska and Maslinska, 2012). At least one agent of each of these 
groups has been added to the World Health Organization's List of Essential Medicines 
(WHO, 2015), underlining their indispensability for human health in the 21st century. 
 
Figure 1. Different classes of antibiotics and their proposed primary mechanism of action on 
bacterial cells (adapted from Kapoor et al., 2017) 
3.2 Bacterial infections in the post-antibiotic era 
The overuse of antibiotics to feed animals and to treat non-bacterial and/or harmless 
infections, resulted in the selection of multidrug resistant (MDR) bacterial strains 
(Michael et al., 2014). Especially worrisome are MDR gram-negative infections (e.g. 
Pseudomans spp.) (Bergogne-Berezin and Towner, 1996). Due to the lack of effective 
new antibiotics, old, dismissed drugs are emerging as important weapons to fight MDR 
gram-negative infections.  
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Figure 2. Comparison of numbers of new antibiotics developed and approved by the Food and 
Drug Administration (FDA) in the US since 1980. Only systemically administered agents are 
shown (Ventola, 2015). 
For instance, vancomycin is back into clinical practice as an efficient antibiotic to treat 
methicillin-resistant Staphylococcus aureus (MRSA) (Nikaido, 2009). Another potent 
antibacterial agent rescued to “save the day” is colistin. Colistin was gradually 
dismissed from clinical use due to kidney toxicity (Koch-Weser et al., 1970).  
Dosing of these old antibiotics are often not optimized through proper pharmacokinetic 
and pharmacodynamic studies. Not surprisingly, colistin administration protocols vary 
considerably among countries. Recent clinical studies pointed out, that colistin dosing 
should be much higher than the protocols currently in use suggest, to maximize the 
antibiotic activity. (Pogue et al., 2015). 
3.3 Pharmacology of antibiotics 
The goal of antibiotic treatment is to support the immune system in the battle against 
the germ. For an optimal response, the administered drug must reach and accumulate 
at the site of infection. Usual routes of administration of antibiotics are by ingestion or 
topical application. More severe cases and aggressive bacterial infections are treated 
systemically. Depending on the chemical and physical properties, some antibiotics, like 
penicillins and cephalosporins, are excreted through the kidneys (Barza and 
Weinstein, 1976; Christ, 1991), others,  like macrolides, by the liver (Periti et al., 1989). 
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The therapeutic window is relatively small for a wide selection of antibiotic drugs. 
Hence the selection of an antimicrobial dosage regimen must be chosen also with 
respect to the physical status of the patient. The dosage is influenced by the 
relationship between target antimicrobial concentrations and the clinical outcomes of 
safety and efficacy. The minimum inhibitory concentration (MIC), used in the past to 
predict the drug efficacy, is now combined with the pharmacokinetic parameters of the 
same drug, also known as pharmacodynamics. Antimicrobial pharmacodynamic 
parameters are: (i) the peak concentration (Cmax):MIC ratio, (ii) the area under the 
concentration-time curve (AUC):MIC ratio, and (iii) the percentage of time that the 
antimicrobial concentration remains above the MIC (T>MIC) (Levison and Levison, 
2009). While the introduction of these parameters has improved the predictivity of 
antibiotic efficacy, the influence of other variables like (i) total versus free, (ii) blood 
versus tissue drug concentration, and (iii) interstitial versus intracellular concentrations 
in relation to the pathogen of interest make it difficult to optimize dosing for most 
antibiotics (Craig, 1998). 
3.4 Antibiotic-induced nephrotoxicity 
Kidney is often the limiting organ during antibiotic therapy; the damage often manifests 
with acute kidney failure and can be monitored by measuring the creatinine levels in 
the patient’s serum. Several factors play a role in renal impairment, for instance a 
relatively high percentage of cardiac output flows through the kidneys exposing them 
to significant amounts of soluble drugs in the blood. Renal elimination is the result of 
three processes, the glomerular filtration, tubular reabsorption and tubular 
secretion.Both reabsorption and secretion are driven by a variety of facilitative 
transport systems that constitute the vectorial transport of solutes and drugs across 
the tubular epithelium (Apell, 2004). Such systems are finely tuned to maintain water, 
nutrients and electrolytes homeostasis, however, when it comes to xenobiotics, 
suboptimal transport often causes tissue injury. For instance, an asymmetrical vectorial 
transport towards the influx (influx > efflux) can occur, leading to anaccumulation of the 
drug in the proximal tubular cells. Alternatively, for antibiotics filtrated through the 
glomerulus into the primary urine, if the water reabsorption is not accompanied by a 
partial reabsorption of the drug, the higher relative concentration of the drug might 
become detrimental during passage through the loop of Henle and the distal tubuli. 
Intracellular accumulation can induce activation of apoptotic pathways or damage the 
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cell irreversibly leading to apoptosis or necrosis. Examples for this active accumulation 
include gentamycin, vancomycin and neomycin and are also suspected to play a role 
in the renal toxicity of the polymyxins. There is growing evidence that certain 
pathophysiological conditions alter the expression levels of many transporters with 
substantial pharmacological ramifications. Our group recently proposed that the long-
standing observation that obese individuals are more susceptible to aminoglycoside-
induced nephrotoxicity is due to the overexpression of the organic cation transporter 2 
(OCT2), which mediates the transport of aminoglycosides from the blood stream into 
the proximal tubular cells (Gai et al., 2016). Other mechanisms of nephrotoxicity 
include mechanical damage through concentration dependent crystallization 
(ciprofloxacin) and inhibition of ion channels required for excretion of sodium and 
potassium (sulfamethoxazole-trimethoprim) (Pazhayattil and Shirali, 2014). 
Figure 3. Proposed mechanisms underlying the cytotoxic effect of gentamicin, an 
aminoglycoside antibiotic notorious for its nephrotoxicity (Lopez-Novoa et al., 2011). 
3.5 Colistin 
Colistin, a polypeptide antibiotic of the polymyxin class, was discovered in the 1950s 
in Japan in Bacillus polymyxa and introduced into the clinic in the following decade 
(Kumazawa and Yagisawa, 2002). Its amphiphilic properties allow it to distribute well 
in polar and non-polar environments and ease its penetration through the outer 
bacterial membrane. According to Falagas et al. “Colistin displaces magnesium (Mg2+) 
and calcium (Ca2+) which normally stabilize the LPS molecules, from the negatively 
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charged LPS leading to a local disturbance of the outer membrane” (Falagas and 
Kasiakou, 2005). It is classified as a bactericidal antibiotic and is not bioavailable when 
taken orally and therefore usually administered intravenously (Kassamali et al., 2015). 
Colistin’s clinical relevant antibacterial reach essentially includes Acinetobacter, with 
the most common strains A. baumanii, Acinetobacter genomic species 3, A. johnsonii 
and A. lwoffii (Bergogne-Berezin and Towner, 1996), MDR Pseudomonas aeruginosa 
and MDR Klebsiella infections (Koomanachai et al., 2007). The most commonly 
observed adverse events of colistin therapy are nephrotoxicity, mainly manifested as 
acute kidney injury (AKI) and mild neurotoxicity. Colistin seems to majorly accumulate 
in the renal cortex regions and its toxic effects on cellular level include heavy damage 
to mitochondria of kidney cells (Nilsson et al., 2015). One suspected mechanism of 
damage derives from the chemical structure of the polymyxins as they contain 
detergent d-aminobutyric acid and fatty acid chains that may induce leakage of the cell 
membrane (Falagas and Kasiakou, 2006). In bacteria, whose cell membranes are 
roughly comparable to human cellular membranes, this fatty acid chain is inserted into 
the membrane lipid bilayer leading to disruption of the membrane. As in bacteria, low 
cytoplasmic content of colistin in eukaryotic cells might be tolerated and interference 
compensated by the cells repair mechanisms. Higher cytoplasmic levels of the drug 
likely put too much stress on structural components of the double lipid layer membrane 
leading to their disintegration. The following uncontrolled passage of ions across the 
membrane influences the delicate osmotic homeostasis of the proximal tubular kidney 
cells and are probably a trigger to a cascade of signals that ends in apoptosis or 
necrosis of the cell. This hypothesis is merely based on the assumption, rather than 
any experimental evidence, that colistin can destroy the eukaryotic plasma membrane 
as well as it does with the bacterial membrane. Theoretical and experimental pitfalls of 
this hypothesis are: (i) bacterial membranes have a very different lipid composition 
(phosphatidylethanolamine and negatively charged lipids) as compared with 
eukaryotic cell membrane (mainly cholesterol), (ii) colistin is selectively toxic towards 
proximal tubular cells, (iii) red blood cells treated with colistin did not display signs of 
haemolysis (Mohamed et al., 2016). Yun and colleagues proposed, by using 
fluorescent-probed polymyxins, that the renal damage induced by polymyxins is 
exerted upon entering the cells (Yun et al., 2015). However, without knowing the 
mechanisms by which colistin enters cells, this question cannot be conclusively 
addressed. Colistin is extensively reabsorbed in the proximal tubule (Li et al., 2003). 
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Colistin is positively charged, thus diffuses poorly across the plasma membrane and 
therefore requires facilitative transport systems to cross the plasma membrane. 
Colistin clearance has been shown to be increased by co-incubation with other cations 
like tetraethylammonium (TEA) and the dipeptide glycine-glycine (Gly-Gly), indicating 
that the renal reabsorption of colistin may involve organic cation transporters and 
peptide transporters (Ma et al., 2009). Lu and colleagues recently found that the 
oligopeptide transporter 2 (PEPT2, SLC15A2) could transport [3H]polymyxin B1 and 
that the uptake was reduced by co-incubation with colistin (Lu et al., 2016). Our group 
recently identified the carnitine and organic cation transporter 2 (OCTN2, SLC22A5) 
as novel transport system that recognizes colistin as a substrate and may contribute 
to the reabsorption of colistin at the apical side of proximal tubule cells (Visentin et al., 
2017).   
3.6 Mitochondrial physiology 
Mitochondria are organelles representing the energy factory of most eukaryotic cells. 
According to the symbiotic theory, they arose from bacteria incorporated by an 
eukaryotic progenitor (Margulis, 1975). Indeed, mitochondria possess their own 
genetic material and still carry many bacterial features. Their prokaryotic origin is also 
considered the most likely explanation of mitochondrial toxicity induced by antibiotics. 
Mitochondria are characterized by two membranes; the outer mitochondrial membrane  
Figure 4. Basic model of human mitochondrial structure (left) and an electron microscope 
recording of mitochondria (right) (Denning, 2007). 
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(OMM) which is relatively permeable to small molecules, and the inner mitochondrial 
membrane (IMM), which is only very selectively permeable and contains a huge variety 
of intramembranous enzymes. In between lies the intramembranous space. The IMM 
encapsulates the mitochondrial matrix (Heidrich et al., 1970).  
We previously defined mitochondria as the energy factory of the cell because one of 
the main task of mitochondria is to produce adenosine triphosphate (ATP), a substance 
whose dephosphorylation, the hydrolysis of ATP is strongly exothermic and is the main 
cellular energy source. Many biological processes are ATP-dependent (e.g. the 
movement of mysoin heads, the active transport of substances across membranes, 
tyrosine kinase signaling). In mitochondria, ATP is formed from ADP and inorganic 
phosphate (Pi) at the end of the electron transport chain by the ATP-synthase. 
Figure 5. Depiction of ATP’s chemical characteristics and its energy mediating capabilities  
(Averill, 2012). 
Glucose, long chain fatty acids and amino acids can be used to produce ATP 
depending on the cell type or status. In the case of glucose, the first series of reaction 
occurs in the cytoplasm of the cell: anaerobic glycolysis yields 2 pyruvate, 2 ATP and 
2 NADH molecules for each molecule of glucose. Pyruvate is converted to lactate in 
hypoxic conditions, like muscle cells during physical activity. When oxygen pressure is 
normal, pyruvate enters the citric acid cycle. Long chain fatty acids are activated into  
long chain acyl-Coa in the cytoplasm, then imported into the mitochondrial matrix via 
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Figure 6. Overview of mitochondrial metabolism, the involved transporters and proteins 
(Freeman, 2008). 
two specific transporters: the carnitine-palmitoyl-transferase I (CPT-I) localized on the 
OMM, and the carnitine palmitoyl-transferase II (CPT-II) in the IMM. In the matrix the 
activated fatty acid are metabolized to acetyl-CoA molecules by a series of reactions 
known as β-oxidation (Milane et al., 2015). In the glycolysis, the citric acid cycle and 
the β-oxidation, the electron carriers NADH and FADH2 are generated. These carriers 
feed the electron transport chain, a series of 4 enzymatic complex integrated in the 
IMM that transfer electrons across the membrane to build a proton gradient, the driving 
force for a rotary turbine-like machine, the ATP-Synthase, which phosphorylates ADP 
to ATP (Jonckheere et al., 2012). Complex I, III and IV catalyze the oxidation of NADH 
to NAD+, Complex II metabolizes Succinate to Fumarate, both resulting in an outwards 
directed relocation of protons in the intermembranous space (Milane et al., 2015; Berg 
2018). In the oxidation of NADH and other processes taking part in the electron 
transport chain, electrons and part of oxygen atoms are combined to form elemental 
water. If the cell is hypoxic (low oxygen pressure), the electron transport chain cannot 
function properly leading to a cascade of detrimental events. In that case, various 
repair mechanisms are activated. However, if the disrupting cannot be fixed 
appropriately, apoptotic pathways can be triggered that ultimately lead to the cells 
death (Milane et al., 2015). The mitochondria itself is part of a complex network of 
regulatory pathways and biochemical sensors that work altogether to guarantee an 
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adequate production of ATP.  An obvious and easy measurable parameter is the matrix 
concentration of ADP and AMP, which rises proportionally to the use of ATP and is 
accessed through the AMP-activated protein kinase (AMPK). Its activation leads to an 
upregulation of catabolic pathways which ultimately lead to an increased production of 
ATP (Mihaylova 2011). Depending on available substrates for the oxidative 
phosphorylation, oxygen levels and other factors, mitochondria can adjust their 
metabolic state into five different states of which each comes with differences in 
intramitrochondrial ADP levels, substrate levels and an altered membrane potential; 
as described by Chance and colleagues (Chance and Williams, 1955; Packer, 1960). 
3.7 Mitochondria and the cell death machinery 
Rasola and Bernardi defined mitochondria as a “firewall that controls the Ca++ 
concentration in the cell and in cytoplasmic microdomains by tuning the frequency of 
oscillatory Ca++ signals and by blunting the spread of cytosolic Ca++ waves” (Rasola 
and Bernardi, 2011). Mitochondria deal with transient cellular Ca++-loads, relieving the 
cell from a burden that would otherwise jeopardize the cell integrity and most likely 
would lead to cell death. However, storing Ca++ can be detrimental for mitochondria as 
well, hence mitochondria are equipped with a fine system to release Ca++ upon 
reaching a certain threshold. The IMM rapidly increases its permeability to ions and 
solutes with molecular masses up to 1500 Dalton, a phenomenon called permeability 
transition (PT) achieved through a voltage-dependent channel sensitive to Ca++ 
(VDAC). This protein complex as been defined as the mitochondrial PT pore (MPTP). 
If the MPTP channel opens for a prolonged time, the resulting alteration of 
mitochondrial homeostasis and ion unbalance activates the intrinsic apoptotic pathway 
or even ends in primary necrosis of the cell if the residual cellular ATP is not sufficient 
to drive the apoptosis. The opening of the MPTP is eased also by oxidative stress, 
elevated phosphate concentration and adenine nucleotide depletion. The opening of 
an MPTP in one mitochondria might lead to a paracrine signal (Ca++ or other diffusible 
signals (e.g. superoxide sparks)) to the surrounding mitochondria and trigger the 
opening of other MPTPs (Halestrap, 2010; Rasola and Bernardi, 2011).  
14 
 
4 Aim 
Colistin, a polypeptide antibiotic of the polymyxin class, has been increasingly 
reintroduced into clinical use in the last decades despite its notorious dose-limiting 
nephrotoxicity, due to the shortage of new antibiotics and the emergence of multidrug 
resistant bacteria. Current colistin therapy regimens are inconsistent, vary greatly 
between different healthcare providers and often cannot reach the target “therapeutic 
concentrations” due to nephrotoxicity. This approach reduces the efficacy of colistin 
and raises the incidence of drug resistant bug colonization. Optimal administration of 
colistin and proper management of the related adverse drug effects remain 
challenging, mostly because the pharmacology of this drug are still largely unknown. 
Although many risk factors for colistin-induced kidney injury have been identified, data 
supporting protective strategies that can buffer nephrotoxicity allowing to widen the 
therapeutic window of colistin, are mostly anecdotal. 
Our group has recently found that mitochondria of mouse primary cultured proximal 
tubular cells exposed to colistin were fully protected by co-incubation with L-carnitine 
(unpublished data). L-carnitine supplementation would be a feasible and safe 
approach to modify colistin therapy and might represent a step forward towards the 
optimization of the treatment of multidrug resistant infections. To do so, the molecular 
mechanisms behind colistin-induced toxicity and L-carnitine protection need to be 
elucidated. 
L-carnitine plays a pivotal role in mitochondria physiology by shuttling long chain free 
fatty acids from the cytoplasm into the mitochondrial matrix where they undergo β-
oxidation, fueling electron transports, mitochondrial membrane potential and, in turn, 
ATP production. We hypothesized that L-carnitine protects from colistin-induced 
mitochondrial damage at two levels: (i) by reducing colistin intracellular accumulation 
by competing for OCTN2, (ii) by protecting the mitochondria.  
The overall aim of this study was to assess the effect of intracellular L-carnitine on 
colistin-induced mitochondrial toxicity and investigate the mechanism behind L-
carnitine mediated protection.  
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5 Materials and Methods 
5.1 Reagents 
ADP (Sigma) 
Alexa Fluor 546 polyclonal goat anti-rabbit (Molecular Probes) 
Colistin sulfate (Sigma) 
Cyclosporin A (Sigma) 
Dulbecco’s modified Eagle’s medium glucose 1g/L (DMEM, Gibco) 
Fatty Free Bovine Serum Albumin (BSA, Sigma) 
Fetal Bovine Serum (FBS, Gibco) 
Gentamicin sulfate (Sigma) 
G418 (Gibco) 
HRP polyclonal goat anti-rabbit (abcam) 
L-carnitine (Sigma) 
L-carnitine [3H] (Amersham) 
Monoclonal rabbit anti-SDHA (Cell Signaling) 
NucBlue Live ReadyProbes Reagent (ThermoFisher Scientific) 
Penicillin (Gibco) 
Phosphate Buffer (PBS, Kanton’s apotheke) 
Polyclonal rabbit anti-TOMM20 (Santa Cruz)  
poly-D-lysine (Sigma) 
Polyethylene Glycol 3,000 (PEG-3000, Sigma) 
Rhodamine 123 (Sigma) 
Streptomycin (Gibco) 
Trypan Blue (Invitrogen) 
Trypsin/EDTA 0.01% (Gibco) 
Vancomycin (Sigma) 
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5.2 Buffer composition 
Isolation buffer: 200 mM mannitol, 50 mM sucrose, 5 mM KH2PO4), 5 mM 3-(N-
morpholino)propanesulfonic acid (MOPS), 0.1 % fatty acid free bovine serum albumin 
(BSA), 1 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid 
(EGTA), pH 7.15 titrated with KOH to pH 7.15. 
 
Laemmli Buffer (loading buffer) 5x: 4 ml 1.5 M Tris-Cl pH 6.8, 10 ml glycerol, 2 g sodium 
dodecyl sulfate (SDS), 1 ml 1% bromophenol blue, pH 6.8, plus 15 mg per 1 ml 1,4-
dithiothreitol (DTT) 
 
Respiration buffer: 130 mM KCl, 5 mM KH2PO4, 5 mM 3-(N-
morpholino)propanesulfonic acid (MOPS), 2.5 mM ethylene glycol-bis(β-aminoethyl 
ether)-N,N,N',N'-tetraacetic acid (EGTA), 3 mM succinate, 0.1 % bovine serum 
albumine (BSA), titrated with KOH to pH 7.15. 
 
Running Buffer: 25 mM tris(hydroxymethyl)aminomethane (Tris), 190 mM glycine, 
0.1% SDS, pH 8.3 
 
Swelling buffer: 120 mM KCl, 10 mM tris(hydroxymethyl)aminomethane (Tris),  5 mM 
KH2PO4, titrated with HCl to pH 7.4  
 
Transfer Buffer: 25 mM tris(hydroxymethyl)aminomethane (Tris), 190 mM glycine, 20% 
methanol, pH 8.3 
 
Transport Buffer: 136 mM NaCl, 5.3 mM KCl, 1.1 mM KH2PO4, 1.8 mM CaCl2, 0.8 mM 
MgSO4, 11 mM D-glucose and 10 mM Hepes, titrated with Tris, pH 7.4 
5.3 Cell Lines 
Wild-type human embryonic kidney 293 cells (WT-HEK293) were maintained in 
Dulbecco’s modified eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum, 100 units/ml penicillin, 100 mg/ml streptomycin at 37°C in a humidified 
atmosphere of 5% CO2. HEK293 cells stably transfected with the coding sequence of 
the organic cation transporter N1 (SLC22A4, OCTN1) were maintained in the same 
conditions as the WT-HEK293 cells and under selective pressure with 800 µg/mL 
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G418. Nearly confluent cells were rinsed with phosphate buffer (PBS), detached from 
the tissue culture plate by incubation (3 minutes at 37°C) with 0.01% trypsin/EDTA 
solution, then neutralized with growth medium. An aliquot of cell suspension was 
diluted 1:1 in 0.04% trypan blue solution andthe cells were counted by automatic cell 
counting (Countess, Invitrogen). Trypan blue dyes the damaged cells selectively, 
allowing discriminating between alive and dead cells.  The density of alive cells was 
used to calculate the experimental seeding conditions. One portion of the cell 
suspension was re-plated for cell line maintenance.  
5.4 Protein determination with bicinchoninic acid (BCA) 
Protein content was measured colorimetrically with the commercially available kit 
Thermo Scientific™ Pierce™ BCA Protein Assay. Reagent A, containing the 
bicinchoninic acid, and reagent B, containing cooper (II) sulfate, were mixed (49:1).  
Two hundred microliters of the final solution were added to 25 μL of sample on a 96-
well plate. The samples were incubated at 37 °C for 30 min then the absorbance at 
560 nm was measured with the GloMax Multi Detection System (Promega). The 
nitrogen of the peptide bond reduces copper ions in alkalin conditions. The reduced 
copper is then chelated by two molecules of bicinchoninic acid generating a purple 
color. The intensity of the color is quantified by measuring the absorbance at 560 nm 
(Smith et al., 1985). A serial dilution of bovine serum albumin was used to produce a 
standard curve and the protein concentration was determined from the calculated 
experimental linear regression.  
5.5 Rhodamine 123 staining, Immunostaining and confocal microscopy 
WT-HEK293 and OCTN1-HEK293 cells were seeded at the density of 5x104 cells/well 
on an 8-well open µ-slide chambered coverslip coated with 0.1 mg/mL poly-D-lysine. 
Lysine is a positively charged amino acid. The resultant net positive charge on the 
surface of the plastic dish eases and strengthens the cell adhesion through 
electrostatic interactions with the negatively charged phospholipid heads of the plasma 
membrane. This allows extensive washing and manipulation of the cell culture, with 
minimal risk of loss of cells through mechanical forces. For the Rhodamine 123 (R123) 
live staining, cells were incubated for 20 min with NucBlue® Live ReadyProbes® 
Reagent to stain the nuclei, washed with PBS, incubated for 20 min with 1 μM R123 in 
respiration buffer at room temperature, then washed again with PBS.  For 
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immunofluorescence, cells were washed in PBS, permealized with 0.1 % Triton for 30 
min and fixed at 37°C for 20 min with 4% Paraformaldehyde in PBS. Then they were 
blocked with 2% BSA in PBS at room temperature for 20 min. Cells were then probed 
overnight for TOMM20 (1:500) at 4°C. Afterwards, cells were washed with PBS, and 
incubated with Alexa 546-anti-rabbit (1:100) at room temperature for 30 minutes, 
washed with PBS and mounted with DAPI. All images were acquired with a confocal 
microscope (Leica DMI6000B).  
5.6 Measurement of intracellular ATP content 
For ATP measurement, CellTiter-Glo® 2.0 Cell Viability Assay was used. Cells were 
lysed with a lysis buffer provided by the kit. The ATP-release triggers the mono-
oxygenation of luciferin by the enzyme luciferase, which generates a 
chemiluminescent signal that is proportional to the amount of ATP present. WT-
HEK293 cells were seeded in 96-well plates at a density of 1x104 cells/well in growth 
medium and incubated at 37°C in a humidified atmosphere of 5% CO2 overnight. 
Afterwards, cells were exposed to the different drugs for 6 h at 37°C in a humidified 
atmosphere of 5% CO2. The treatment was stopped by aspirating the medium and 
lysing the cells in Promega CellTiter-Glo® 2.0 buffer. Forty μL of each well were then 
transferred to a new 96-well plate and serial dilution of a standard solution of ATP was 
used to evaluate the linear correlation between chemiluminescent signal and ATP 
concentration. Data were normalized for the protein content measured as previously 
described. 
5.7 Isolation of functional mitochondria 
For isolation of functional mitochondria from cell culture, WT-HEK293 cells were grown 
to 85-95% confluence on 500 cm2 tissue culture plates at 37 °C in a humidified 
atmosphere in 5% CO2. To harvest, cells were washed 3 times with cold PBS, re-
suspended in 10 mL of cold isolation buffer (IB) and transferred in 50 mL Sorvall 
centrifuge tubes. Cell suspension was then centrifuged in a SS34 rotor (Sorvall) for 10 
min at 4°C at the speed of 2000 rpm.  The pellet was re-suspended in 3.5 mL cold IB 
and homogenized in a 5 mL Teflon homogenizer at 1600 rpm. The homogenization 
speed is critical to destroy cells/tissues without damaging the mitochondria. For 
isolation of functional mitochondria from mouse kidney, the mouse was sacrificed; the 
kidneys were excised and homogenized as described above. The homogenate was 
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then centrifuged in a SS34 rotor for 5 min at 4 °C at 3000 rpm to separate nuclei and 
unbroken cells (pellet) from intracellular compartments (supernatant). The pellet was 
kept at -20°C until use. The supernatant was further centrifuged in a SS34 rotor for 10 
min at 4 °C at 10000 rpm. The pellet was re-suspended and transferred into a 1.5 mL 
tube and spun down for 10 min at 4 °C at 10000 x gav.The pellet containing the 
mitochondria was used immediately for functional assays (R123 uptake or swelling 
experiment) or kept at -20°C for western blot. The supernatant was ultra-centrifuged in 
a Centrikon T-1170 centrifuge for 1 hour at 4 °C at 100000 x gavand the pellet was 
stored at -20°C for western blot analysis. 
5.8 Western blot 
The western blot consists of three main steps:  
1. Separation of the protein according to the molecular weight. To separate the 
proteins onto a 12% polyacrylamide gel, 8 ml of Acrylamide Bis 30% were 
combined with 6.8 ml of deionized water, 0.2 ml of Ammonium persulfate (APS) 
and 0.015 ml of N,N,N',N'-Tetramethylethylendiamin (TEMED). The APS and 
TEMED induce the radical reaction that lead to the polymerization into a mesh-like 
structured gel. To ensure all samples starting the separation at once, a stacking 
gel (4.2 ml of deionized water, 0.9 ml Acrylamide Bis 30%, 0.07 ml of APS and 
0.011 ml of TEMED) was prepared and poured on top of the resolving gel. Forty 
µg of protein were re-suspended in Laemmli buffer, de-naturated at 85°C for 15 
minutes and loaded into the stacking gel. The presence of the anionic surfactant 
sodium dodecyl sulfate (SDS) in the Laemmli buffer overlays the proteins and 
leads to formation of negatively charged complexes whose charge correlates 
roughly with the size of the protein (Smith, 1994). This guarantees separation is 
based solely on size of the protein independent from their respective charge. By 
applying an electric field (150 V); the proteins migrate from the negative to the 
positive pole. The bigger the protein, the slower is the migration through the gel. 
The protein separation was monitored by co-running a pre-stained protein ladder 
(marker), a mixture of 9 proteins with different sizes. As soon as the smallest and 
therefore fastest proteins of the marker reached the other end of the gel, the run 
was stopped by discontinuing the electric flow. 
2. Transferring of the separated protein on a membrane. The gel was “sandwiched” 
together with a PVDF membrane previously activated by soaking in methanol. The 
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surface of the PVDF membrane is strongly hydrophobic and would not bind the 
proteins if directly exposed to the aqueous transfer buffer. The “sandwich” was 
immersed in transfer buffer and an electric field (250 mA) was applied for ~ 1h to 
transfer the proteins from the gel onto the membrane. The negatively charged 
protein fractions will then migrate along the electric potential difference from the 
gel onto the membrane. The complete transfer of the marker onto the membrane 
serves as control of a successful transfer of the proteins. 
3. Probing of the membrane with a certain antibody to detect the protein of interest. 
The membranes were blocked for 1 hour at room temperature or overnight at 4°C 
with 5% nonfat dry milk and 0.1% Tween-20 in PBS (blocking buffer).  Afterwards 
the membranes were incubated for 1h with the desired primary antibody diluted in 
blocking buffer, then washed three times with blocking buffer, followed by 1h 
incubation with the appropriate horseradish peroxidase conjugated secondary 
antibody diluted in blocking buffer as well and 3 washing steps in blocking buffer 
and 2 washing steps with PBS-T. 
5.9 Measurement of Rhodamine 123 uptake in isolated mitochondria 
Rhodamine 123 (R123) is a lipophilic dye that specifically accumulates in mitochondria 
depending on the mitochondrial membrane potential and those chemical agents that 
collapse membrane potential (e.g. uncoupler, complex inhibitors) prevent uptake of 
R123 by mitochondria (Chen, 1988). R123 uptake can be monitored in non-quenching 
or quenching mode. 
To measure the uptake of R123 in isolated mitochondria, R123 was dissolved in 
respiration buffer to a final concentration of 10 µM. The fluorescence emission at 538 
nm of the R123 solution was measured, then a 5 µL aliquot of isolated mitochondria 
was mixed into the R123 solution and the decline of fluorescence intensity at 538 nm 
was monitored over the time.  The accumulation of R123 leads to its aggregation which 
induces a red shift of fluorescence and extensive quenching of the emission at 538 nm 
(Perry et al., 2011). Loss in fluorescence signal in presence of mitochondria is 
considered an indicator of intact mitochondrial membrane potential (Emaus et al., 
1986).  
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5.10 Assessment of mitochondrial swelling 
An increase in volume of the isolated mitochondria leads to a macroscopic dilution of 
light absorbing substances in the mitochondrial matrix while a decrease in volume 
leads to a relative concentration of light absorbing substances. This phenomenon can 
be exploited to understand the effect of drugs on the morphologic state of the 
mitochondria. Isolated mitochondria were resuspended at the final concentration of 
0.25 mg/mL in swelling buffer containing the different compounds to test and the 
absorption at 560 nm was measured with GloMax® Spectrophotometer (Promega). 
5.11 Transport assay in intact cells 
WT-HEK293 and OCTN1-HEK293 cells were seeded at a density of 1,5x105 on 35-
mm dishes coated with 0.1 mg/ml poly-D-lysine and incubated at 37°C in a humidified 
atmosphere in 5% CO2 until 85-95% confluence was reached.  The medium of the WT-
HEK293 and OCTN1-HEK293 cells was aspirated and the cells were washed and 
equilibrated with pre-warmed transport buffer. Afterwards, transport buffer containing 
[3H]L-carnitine was added. Uptake was stopped by quick aspiration followed by 
extensive washing with ice-cold transport buffer. Subsequently, cells were lysed with 
1 ml of 1% Triton x100 for 40-50 minutes and 500 l were mixed with 3 ml of scintillation 
liquid and assessed for intracellular radioactivity with a scintillation counter (Canberra 
Industries). Twenty-five microliter of the remaining solution were assessed for protein 
determination as previously described.  
5.12 Statistical analysis 
Statistical comparisons were performed from at least three independent 
measurements, using GraphPad Prism (version 5.0 for Windows, GraphPad 
Software).  
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6 Results 
6.1 Uptake of L-carnitine in WT-HEK293 cells and OCTN1-HEK293 cells  
Data from our group (Visentin et al., 2017) showed full protection of primary cultured 
proximal tubular cells from the toxic effects of colistin when co-incubated with L-
carnitine. L-carnitine and colistin share the same transport system, OCTN2, however 
such protection might be only partially ascribed to the interaction at the OCTN2 level. 
To understand the impact of intracellular L-carnitine on colistin-induced toxicity, we 
exploited the substrate specificity of OCTN1. OCTN1 does not interact with colistin 
(Visentin et al., 2017) and is a low affinity transporter for L-carnitine (Yabuuchi et al., 
1999). The uptake of [3H]L-carnitine in WT-HEK293 cells was compared with that in 
OCTN1-HEK293 cells. Cells were incubated for 10 minutes with [3H]L-carnitine at the 
extracellular concentration of 1 M, a concentration that resembles that of the growth 
medium (Baker et al., 1988). As illustrated in figure 7, the intracellular level of [3H]L-
carnitine was notably higher in the OCTN1-HEK293 cells as compared with the WT-
HEK293 cells (17.72 ± 3.2 vs 24.96 ± 4.2, P=0.03). 
Figure 7. Uptake of [3H]L-carnitine in WT- and OCTN1-HEK293 cells. Cells were exposed 
for 10 minutes to [3H]L-carnitine at the extracellular concentration of 1 M. Data represent the 
mean ± S.D. from three independent experiments. 
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6.2 Effect of colistin on mitochondrial membrane potential and 
mitochondrial integrity 
We demonstrated that OCTN1-HEK293 cells had a higher intracellular level of L-
carnitine. If intracellular L-carnitine could protect from colistin-induced toxicity, cells 
overexpressing OCTN1 would be more resistant to colistin than the respective wild-
type cells. WT-HEK293 and OCTN1-HEK293 cells were exposed for 48h to colistin at 
an extracellular concentration of 100 M then stained with 1 M R123. The ability of 
mitochondria to generate and sustain a membrane potential across the inner 
membrane is the pre-requisite for mitochondrial function and cell survival. R123 
specifically accumulates in mitochondria depending on the mitochondrial membrane 
potential (Chen, 1988). When the MMP collapses, R123 accumulation is inhibited. 
Figure 8. Colistin-induced mitochondrial damage in WT-HEK293 cells. WT-HEK293 cells 
were exposed to colistin at an extracellular concentration of 100 µM for 48 hours. 
Representative R123 staining (a and b) and TOMM-20 immunofluorescence (c and d). 
24 
 
Figure 8 shows that colistin exposure induced a marked reduction of the R123 green 
fluorescent signal, indicating mitochondrial membrane depolarization. In parallel, cells 
were probed for TOMM-20, a mitochondrial import receptor subunit that localizes on 
the mitochondrial outer membrane, to evaluate the impact of colistin on mitochondrial 
membrane integrity. It can be seen that in cells exposed to colistin, the TOMM-20 
signal was similar to that from the untreated cells, suggesting that mitochondria 
integrity was not affected by colistin. Figure 9 shows that colistin exposure did not affect 
either R123 or TOMM-20 signal in OCTN1-HEK293 cells, suggesting that 
mitochondrial function and integrity were maintained.   
Figure 9. Mitochondrial toxicity induced by colistin. OCTN1-HEK293 cells were exposed 
to colistin at an extracellular concentration of 100 µM for 48 hours. Representative r123 
staining (a and b) and TOMM-20 immunofluorescence (c and d). 
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6.3 Functional assessment of isolated mitochondria from WT-HEK293 
cells 
To understand whether the mitochondrial dysfunction (Figure 8) was the primary and 
central effect  of colistin exposure, or rather a secondary one in a chain of damage 
events, we set up a method to test the direct effect of colistin on the function of isolated 
mitochondria. Mitochondria were enriched through different centrifugation steps 
(Frezza et al., 2007). The mitochondrial fraction enrichment was evaluated by Western 
blot. From the subcellular fractionation 3 pellets were collected. As mitochondrial 
marker we used the mitochondrial import receptor subunit (TOMM-20) and the 
succinate dehydrogenase complex flavoprotein subunit A (SDHA),  which are localized 
at the outer and inner membrane, respectively. Figure 10 shows that both TOMM-20 
and SDHA signals were detected in pellet 1, indicating that the mitochondria were 
successfully enriched in a single fraction. It can be seen that TOMM-20 was also 
partially detected in the pellet 3, likely as result of a contamination from broken 
mitochondria. Pellet 1 was used for further experiments in isolated mitochondria. The 
mitochondrial fraction was assessed for membrane potential and proton gradient by 
R123 uptake in isolated mitochondria. Mitochondria at a final concentration of 0.25 
mg/ml were mixed with 10 M R123 solution and the decline of fluorescence was 
monitored. R123 fluorescence spectrum shifts to the red in response to mitochondria 
energization (self-quenching) leading to a decreased emission at 538 nm (Emaus et 
al., 1986). The control is represented by the fluorescence intensity before the 
mitochondria were added. There is an empirical linear relationship between 
fluorescence intensity change and membrane potential (Chen, 1988). Figure 11 shows 
that untreated mitochondria induced a rapid decrease of fluorescent signal, suggesting 
a healthy state of the mitochondrial membrane potential. When mitochondria were 
exposed to the mitochondrial uncoupler Na-Salicylate, the fluorescence quenching 
was trivial as result of a collapsed membrane potential. Mitochondrial uncouplers are 
protonated weak lipophilic acids (A-H+) that dissolve in the inner membrane and diffuse 
through the lipid phase into the matrix compartment where they dissociate into the acid 
anion (A-) and H+, thereby dissipating the proton gradient (Smith and Moses, 1960). 
However, they do not accumulate in the matrix because their anion is also soluble in 
the lipid phase due to the charge delocalizing over their aromatic ring. The acid anion 
is expelled from mitochondria down the gradient of membrane potential (more positive 
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outside), thereby dissipating the gradient. This futile proton-shuttling cycle is repeated 
until there is no more gradient across the inner membrane.  
Figure 10. Representative immunoblot of TOMM-20 and SDHA in subcellular fractions 
from WT-HEK293 cells. Forty g of protein samples from the subcellular fractions were 
processed as described in Materials and Methods and probed with anti-TOMM20 or anti-
SDHA. The black vertical line indicates reprobing from the same gel. 
Figure 11. Time-course of R123 fluorescent signal in isolated mitochondria from WT-
HEK293 cells. Mitochondria were resuspended in respiration buffer and mixed with 10 M 
R123 solution in the presence or absence of Na-salicylate, and the fluorescence intensity at 
538 nm was monitored. The black arrow indicates the time points at which mitochondria were 
added. Data are expressed as percentage of the fluorescent intensity before the mitochondria 
were added.  
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6.4 Energy state of mitochondria isolated from WT-HEK293 cells 
exposed to colistin 
The impact of colistin exposure on the energy state of mitochondria was evaluated in 
WT-HEK293 cells after 48-hour incubation with colistin 500 µM or Na-Salicylate 5 mM. 
From the cells, mitochondria were extracted and protein content determined as 
previously described. Mitochondria at a final concentration of 0.25 mg/ml were 
exposed to a R123 10 µM solution and the fluorescence decay was monitored over 
time. Figure 12 shows that mitochondria from cells exposed to colistin displayed a 
reduced uptake of R123, suggesting a partial depolarization.  
Figure 12. Time-course of R123 fluorescent signal in isolated mitochondria from WT-
HEK293 cells. Isolated mitochondria were resuspended in respiration buffer and mixed with 
10 M R123 solution and the fluorescence intensity at 538 nm was monitored. The black arrow 
indicates the time points at which mitochondria were added. Data are expressed as percentage 
of the fluorescent intensity before the mitochondria were added. 	
6.5 Impact of colistin exposure on ATP production in WT-HEK293 cells 
The main role of mitochondria is to generate ATP through oxidative phosphorylation. 
To assess the effect of colistin on intracellular ATP levels, WT-HEK-293 cells were 
exposed for 48 hours to the indicated concentrations of colistin, then the cells were 
lysed and the intracellular ATP levels were measured using Promega CellTiter-Glo® 
2.0 Cell Viability Assay. Data were normalized for protein concentration. Figure 13 
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shows, that colistin exposure did not alter the intracellular levels of ATP. Notably, the 
treatment with oligomycin, a potent inhibitor of the H+-ATP-Synthase, did not affect the 
intracellular levels of ATP significantly (P=0.24). Taken together the data suggest that 
WT-HEK293 cells did not rely on mitochondria-dependent ATP production.  
Figure 13. Measurement of intracellular ATP in WT-HEK293 cells treated with colistin. 
Cells were exposed for 48 hours to colistin at the indicated concentrations, then ATP levels 
were measured. Data are expressed as percentage of the luminescent intensity from untreated 
cells (control). Data represent the mean ± S.D. from three independent experiments. 
6.6 Effect of colistin on isolated mitochondria from WT-HEK293 cells 
and from mouse kidney  
To understand whether the mitochondrial dysfunction (Figure 8) was the primary effect 
of colistin exposure, or rather a consequence of other damaging events, R123 uptake 
by isolated mitochondria from WT-HEK293 cells was monitored in the presence or 
absence of colistin. In figure 15 it can be seen that colistin could induce a dose-
dependent reduction of R123 accumulation (reduced quenching), suggesting a direct 
effect of colistin on mitochondrial membrane potential. Because mitochondria energy 
state can vary among tissues and cell types (Chance and Williams, 1955), we 
assessed the effect of colistin on mitochondria freshly extracted from mouse kidney. 
As observed in mitochondria extracted from WT-HEK293 cells, R123 uptake was 
reduced in presence of colistin, indicating membrane depolarization. In another setting 
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(Figure 16), mitochondria isolated from mouse kidney were incubated for 1 min with 
R123 solution then added with colistin (black arrow) to the indicated final 
concentrations. It can be seen that the colistin-induced mitochondrial dysfunction lead 
to a partial release of the intramitochondrial R123 as reflected by the enhanced 
fluorescent signal.  
Figure 14. Time-course of R123 fluorescent signal in isolated mitochondria from WT-
HEK293 cells. Mitochondria were resuspended in respiration buffer and mixed with 10 M 
R123 solution and the fluorescence intensity at 538 nm was monitored. The black arrow 
indicates the time points at which mitochondria were added. Data are expressed as percentage 
of the fluorescent intensity before the mitochondria were added.  
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Figure 15. Time-course of R123 fluorescent signal in isolated mitochondria from mouse 
kidney. Mitochondria were resuspended in respiration buffer and mixed with 10 M R123 
solution and the fluorescence intensity at 538 nm was monitored. The black arrow indicates 
the time points at which mitochondria were added. Data are expressed as percentage of the 
fluorescent intensity before the mitochondria were added.  
Figure 16. Time-course of R123 fluorescent signal in isolated mitochondria from mouse 
kidney. Mitochondria were resuspended in respiration buffer and mixed with 10 M R123 
solution and the fluorescence intensity at 538 nm was monitored. The black arrows indicate 
the time points at which mitochondria and the drugs were added. Data are expressed as 
percentage of the fluorescent intensity before the mitochondria were added. 
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6.7 Impact of other nephrotoxic antibiotics on isolated mitochondria 
from mouse kidney  
Mitochondrial toxicity has been proposed also for other recognized nephrotoxic 
antibiotics as aminoglycosides (Davey et al., 1970)  and vancomycin (Arimura et al., 
2012). We assessed the impact of gentamycin (a member of the aminoglycoside 
family) and vancomycin on mitochondrial membrane potential in comparison with 
colistin. Figure 17 shows the effect of gentamycin 1 mM and vancomycin 1 mM in 
comparison with colistin 1 mM on the R123 uptake of isolated mitochondria from 
mouse kidney cells. The effect of the former two showed to be less pronounced. This 
indicates that vancomycin and gentamycin interfere with the mitochondrial membrane 
potential to a lesser extent. This comparison also further accentuates the depolarizing 
effect of colistin on the mitochondrial membrane and underlines the probability of 
involvement of mitochondria in its toxicity.  
Figure 17. Time-course of R123 fluorescent signal in isolated mitochondria from mouse 
kidney. Isolated mitochondria from mouse kidney tissue were resuspended in respiration 
buffer and mixed with 10 M R123 solution and the fluorescence intensity at 538 nm was 
monitored. The black arrows indicate the time points at which mitochondria and the different 
drugs were added. Data are expressed as percentage of the fluorescent intensity before the 
mitochondria were added. 
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6.8 Effect of co-incubation of inhibitors of the MPTP 
The main sensor of mitochondrial function is the mitochondrial permeability transition 
pore (MPTP) (Lemasters et al., 1998). The opening of the MPTP can be a cause or a 
consequence of the membrane potential depolarization. To understand whether 
colistin-induced depolarization was dependent on the MPTP opening we reviewed the 
literature for documented MPTP opening inhibitors. We found very well-characterized 
inhibitors such as ADP (Sokolova et al., 2013) and cyclosporine A; other reports 
suggested that L-carnitine and fatty acid-free bovine serum albumin (BSA) could also 
inhibit the opening of the pore (Li et al., 2015; Hurst et al., 2016). We tested the effect 
of these compounds on colistin-induced depolarization. 
Figure 18 shows that mitochondria co-incubated with ADP were not sensitive to 
colistin. The other MPTP inhibitors cyclosporin A, L-carnitine and BSA failed to protect 
from membrane depolarization. 
Figure 18. Time-course of the R123 fluorescent signal in isolated mitochondria from 
mouse kidney. Isolated mitochondria from mouse kidney were resuspended in respiration 
buffer and mixed with 10 M R123 solution and the fluorescence intensity at 538 nm was 
monitored. The black arrows indicate the time points at which mitochondria and colistin were 
added. Data are expressed as percentage of the fluorescent intensity before the mitochondria 
were added. 
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6.9 Mitochondrial swelling experiment with WT-HEK293 cells 
MPTP opening induces mitochondrial swelling. To assess the effect of colistin on 
mitochondrial volume, isolated mitochondria were resuspended in swelling buffer, then 
exposed to colistin and the optical absorbance at 560 nm was monitored. Swelling of 
mitochondria is accompanied by a reduced light scattering (decreased absorbance), 
vice versa, shrinking of mitochondria is reflected by an increased absorbance. Isolated 
mitochondria were diluted at a final concentration of 0.25 mg/mL in swelling buffer 
containing the indicated solutions. Absorption was monitored at 560 nm and is shown 
in Figure 19. CaCl2 was used as positive control for mitochondrial swelling. 
Mitochondria exposed to CaCl2 at the extracellular concentration of 500 M showed   
 20% decrease in absorption (P<0.05) as a result of solutes and water influx through 
the open MPTP. Polyethylene glycol 3000 (PEG-3000) should induce water efflux by 
exerting an oncotic pressure against the mitochondrial outer membrane and, in turn, 
shrinking of the mitochondria. It can be seen that mitochondria exposed to PEG-3000 
displayed a slightly higher (5%) light scattering as compared tothe control. 
Mitochondria exposed to colistin showed significant increase in absorption in a dose-
dependent manner with a mean increase of approx. 22% (P<0.001) and 32% 
(P<0.0001) respectively. This strongly suggests significant shrinking of mitochondria 
exposed to colistin in a concentration dependent manner. 
Figure 19. Assessment of mitochondrial morphology after exposure to colistin. Isolated 
mitochondria were transferred to 96-well plates and different treatments applied. Absorption 
was measured at 562 nm. Data are expressed as percentage of the absorption intensity 
relative to the untreated control and as mean ± S.D. Multiple analysis was performed by one-
way ANOVA test. Dunnett test was used for Post Hoc. 
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7 Discussion 
The proposed model of colistin induced-nephrotoxicity is based on electrostatic 
interaction of its cationic structure and the interference of its D-amino acid content as 
well as the fatty acid component with the eukaryotic cellular membrane. A possible 
result isthe influx of cations, anions and water, with subsequent cell swelling and lysis 
(Falagas and Kasiakou, 2006). Such a mechanism assumes that mammalian and 
bacterial cell membranes are similar. However, the biochemical composition of 
eukaryotic cell membranes differs substantially from that of bacteria. Gram-negative 
bacteria outer cell membranes contain a significant amount of negatively charged lipids 
(phosphatidylglycerol and cardiolipins) whereas eukaryotic cell membranes are 
enriched in cholesterol and their outer layer is essentially neutral. These differences in 
net charge and lipid contents make electrostatic interference with, and insertion into, 
mammalian membranes of colistin, a five-fold positively charged cationic polypeptide, 
unlikely. Consistently, no obvious hemolytic events were observed when mammalian 
erythrocytes were exposed to cationic polypeptides (Glukhov et al., 2005). On the other 
hand, gram-negative bacteria membranes are evolutionary close to the mitochondrial 
membranes, making the interaction with colistin more likely. We demonstrated that 
mitochondria of WT-HEK293 cells were completely depolarized upon colistin 
exposure. Despite the dramatic effect at the membrane potential level, we did not 
appreciate any macroscopic change in TOMM-20 staining in cells treated with colistin, 
suggesting that membrane depolarization was an early event in colistin-induced 
mitochondrial toxicity. Furthermore, higher level of intracellular L-carnitine, an 
important co-factor in mitochondria energy state, could protect WT-HEK293 cells from 
colistin-induced mitochondrial damage.  
The membrane potential across the inner membrane of mitochondria is ~ 220-240 mV 
and consists of the mitochondrial membrane potential (Δψ, a charge or electrical 
gradient) and the mitochondrial pH gradient (ΔpH, an H+ chemical or concentration 
gradient) (Mitchell and Moyle, 1969). The net accumulation of H+ outside the inner 
membrane then flows back into the mitochondria through the ATP-generating F1/F0 
ATP-synthase, thus producing ATP from ADP + Pi. Hence, the mitochondrial 
membrane depolarization would result in a rapid drop of the cellular ATP levels. The 
ATP content from WT-HEK293 cells exposed to colistin for 48 hours was similar to that 
of untreated cells, in apparent contradiction with the marked membrane depolarization 
observed in similar experimental conditions. The possible explanation for this 
conflicting data might lie in a metabolic switch often observed in culture cells. Cell lines 
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are metabolically adapted for rapid growth under hypoxic and acidic conditions, and 
they derive almost all of their energy from glycolysis rather than via mitochondrial 
oxidative phosphorylation (OXPHOS), despite the presence of competent 
mitochondria. Such adaption is known as Crabtree effect (Crabtree, 1929). In such 
cells, mitochondrial toxins have little effect on cell growth or viability (Marroquin et al., 
2007). In line with this, oligomycin is a potent inhibitor of the F0 subunit of H+-ATP-
synthase but failed to lower cellular ATP contents of exposed WT-HEK293 cells. The 
Crabtree effect can be by-passed by growing the cells in a galactose growth medium: 
galactose-derived glycolysis yields no net ATP, forcing the cells to rely on 
mitochondrial ATP production (Marroquin et al., 2007). The potency of oligomycin to 
deplete the intracellular level of ATP production increases by 5 orders of magnitude in 
a galactose growth medium (IC50gal=3 nM, IC50glu=300 M) (Swiss et al., 2013). 
The membrane depolarization induced by colistin might begin with an alteration of the 
membrane permeability via mechanical damage to the outer mitochondrial membrane 
(OMM), which resembles the lipid composition of gram-negative cells. A number of 
studies have shown that polymyxins induce a concentration dependent transition in 
mitochondrial morphology from filamentous to fragmented shape, which was 
interpreted as a sign of stress (Azad et al., 2015). Damage to mitochondrial 
ultrastructure and alteration of expressed enzymes after exposure of neuronal cells to 
clinical doses of colistin have also been observed (Dai et al., 2013a). It seems unlikely 
that a solely increased OMM-permeability can induce membrane depolarization. It has 
been reported that permeabilized mitochondria can sustain the membrane potential 
and the mitochondrial function through the release of cytochrome c (Waterhouse et al., 
2001). More likely, the increased OMM-permeability could ease the access of colistin 
to the intramembranous space that might otherwise be difficult in consideration of the 
cationic nature of colistin.  
Colistin might also induce the opening of the mitochondrial permeability transition pore 
(MPTP). The MPTP is a mitochondria-specific protein complex spanning the outer and 
the inner membranes. A permanent opening of this pore allows molecules of up to a 
size of 1’500 Dalton to pass freely through the outer and inner membrane with dramatic 
changes in mitochondrial homoeostasis and result in dissipation of the proton gradient, 
depolarization and induction of apoptotic or necrotic signals. The main factor for MPTP 
opening is the raise of the Ca++ concentration in the matrix (Hurst et al., 2016). One 
hypothesis is that the mitochondrial shrinkage induced by colistin might raise the 
concentration of Ca++ in the matrix, which, in turn, would induce the opening of the 
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pore. An increased mitochondrial permeability in mitochondria from kidney of mice 
exposed to colistin has been reported (Dai et al., 2014). In our setting colistin-induced 
depolarization of the mitochondrial membrane was completely abolished when isolated 
mitochondria were co-incubated with ADP, a known inhibitor of the MPTP (Sokolova 
et al., 2013). When cyclosporine A was used to inhibit the opening of the pore, no 
protection was observed. This is consistent with previous work which demonstrated 
that cyclosporine A’s inhibitory effect was reduced in shrunken mitochondria (Hurst et 
al., 2016). Interestingly, L-carnitine, which was also reported to inhibit the opening of 
the pore (Virmani et al., 2003) did not protect the isolated mitochondria from colistin-
induced depolarization. L-carnitine may still protect the cells by inhibiting the opening 
of the MPTP, but in an indirect fashion.  
The mitochondrial stress induced by colistin has already been reported both in vitro 
(Dai et al., 2013b) and in vivo (Dai et al., 2014). None of these studies could define 
whether colistin directly interacted with mitochondria, thus representing a primary 
event in colistin-induced damage, or if the observed long-term damage was just part 
of the apoptotic or necrotic machinery. To the best of our knowledge, this is the first 
evidence that colistin directly interacts with mitochondria inducing a rapid 
depolarization of the mitochondrial membrane potential within seconds. Mitochondrial 
depolarizing agents can be classified as uncouplers and inhibitors. Typical uncouplers 
are carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), carbonyl cyanide 
m-chlorophenyl hydrazone (CCCP), Na-salicylate and free fatty acids. Such molecules 
are usually weak anions that act as ionophores and bring H+ across the mitochondrial 
membranes, dissipating the proton gradient. The presence of a short fatty acid chain 
might confer some uncoupling properties to colistin (Broekemeier and Pfeiffer, 1995; 
Di Paola and Lorusso, 2006). However, considering the whole peptide colistin is highly 
cationic in nature, the possibility of it acting as an uncoupler may be limited. 
The membrane potential across the inner membrane is generated as oxidized 
substrates (e.g. pyruvate, succinate) release electrons to cofactors such as NADH or 
FADH2. These electrons are passed through electron carriers in respiratory chain 
complexes with increasing oxidation potentials, ultimately reducing molecular oxygen 
to water. If one of this complex is inhibited the electrochemical gradient across the 
inner membrane cannot be sustained resulting in membrane depolarization. Many 
drugs (including antibiotics) and toxins have been shown to induce mitochondrial 
stress by inhibiting the electron transport chain. Amytal, a barbiturate, blocks the 
electron transfer between NADH dehydrogenase and coenzyme Q and therefore 
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inhibits complex I (Ernster, 1963). Lonidamin, an anticancer agent inhibits the 
succinate-ubiquinone reductase activity of complex II (Guo et al., 2016). Antimycin A, 
an antibiotic produced by Streptomyces griseous that is used as a piscicide, inhibits 
complex III of the electron transport chain by binding to its bc1 segment (Berden and 
Slater, 1972). Potassium cyanide (KCN) inhibits complex IV of the respiratory chain by 
binding to the Fe+++ in the hem-group of cytochrome C (Jensen et al., 1984). In our 
experimental setting, succinate was employed as substrate. Because succinate is a 
substrate for complex II, it is unlikely that the colistin-induced depolarization is due to 
an interaction at the level of complex I. Inhibition of complex II, III and IV by colistin 
cannot be ruled out. While complex I-IV contribute to the generation of the membrane 
potential, the H+-ATP-synthase dissipates the potential by using the protons 
accumulated at the interspace to generate ATP. The inhibition of the H+-ATP-synthase 
with the antibiotic oligomycin, in presence of a function electron transport, increases 
the membrane potential (hyperpolarization) (Perry et al., 2011). Our data indicates that 
an interaction between colistin and the H+-ATP-synthase is unlikely. 
Protecting mitochondria with L-carnitine from colistin is an intriguing strategy to 
implement colistin pharmacology. The average plasma concentration of L-carnitine is 
~ 15-50 M, depending on age and gender among other factors (Vaz and Wanders, 
2002). L-carnitine is mainly reabsorbed in the tubules by OCTN2 with an influx Km of  
~ 5 M, indicating that under physiological conditions OCTN2 is nearly saturated and 
L-carnitine supplementation would fail to increase its intracellular levels. Children 
lacking a functioning OCTN2 are affected by primary systemic carnitine deficiency 
(SCD; OMIM 212140) (Nezu et al., 1999). However oral L-carnitine supplementation 
can sustain normal plasma levels of L-carnitine in these patients, suggesting that, at 
supraphysiological levels, other carriers (e.g. OCTN1) could mediate L-carnitine 
reabsorption. Intravenous administration of L-carnitine could reach a plasma peak of 
200 M and effectively raise its intracellular levels possibly to the point of protection 
from colistin damage (Rasmussen et al., 2015). 
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